![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|6|1|7-16
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.1, 2006-01, pp. : 7-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Role of Transmembrane Segment II in 7TM Receptor Activation
Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
7 Receptor-selective agonists and modes of 7 receptor activation
By Papke R.L. Meyer E. Nutter T. Uteshev V.V.
European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ligand efficacy and affinity in an interacting 7TM receptor model
Trends in Pharmacological Sciences, Vol. 20, Iss. 7, 1999-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Receptor dimerization and Hill coefficients
Trends in Pharmacological Sciences, Vol. 20, Iss. 9, 1999-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reply: beyond receptor dimerization
Trends in Pharmacological Sciences, Vol. 21, Iss. 9, 2000-09 ,pp. :